Dominican Republic Bolsters Tuberculosis Diagnosis with New GeneXpert Equipment
The Ministry of Health in the Dominican Republic recently announced the acquisition of two GeneXpert devices to enhance molecular detection of tuberculosis (TB) within public healthcare systems. This investment—a total of RD 3,377,100.00—marks a significant step in the national effort to increase rapid and accurate TB diagnostics across the country.
Importance of GeneXpert Technology
The introduction of these new machines boosts the total GeneXpert devices in the public network to 36, significantly improving diagnostic capabilities. These advanced devices facilitate quick testing, which is crucial for timely treatment, potentially saving lives and mitigating the spread of the disease.
Recent Tuberculosis Statistics
In 2025, the National Tuberculosis Control Program (PNCT) reported 4,447 new TB cases. Notably, 855 of these cases were linked to individuals with TB/HIV co-infections. Moreover, the recorded mortality rate stood at 0.6 per 100,000 inhabitants, highlighting the ongoing public health challenge TB poses in the region.
A Step Forward in Healthcare
Julio Landrón, the director of the National Health Service (SNS), emphasized that these new GeneXpert devices represent much more than equipment; they are an investment in lives. “Each timely diagnosis increases the chances of recovery, reduces complications, and decreases transmission risk,” he stated, underscoring the technology’s crucial role in fighting TB.
Expansion of Diagnostic Coverage
Data from the SNS reveals a significant uptick in TB testing, with 31,047 molecular tests conducted in 2025. As of early 2026, 2,254 new cases have been identified, with all patients currently undergoing treatment. The public health initiative aims to exceed 92% coverage of its TB program through 1,523 health facilities throughout the nation.
Ministerial Perspectives
Minister Atallah confirmed that the new equipment aligns with the government’s objective of guaranteeing universal access to essential diagnostic and treatment services. “Our vision is to create a future free from the threat of TB,” he asserted, emphasizing that each new machine paves the way for earlier detection and timely intervention.
Eladio Perez, the vice minister of Collective Health, further remarked on the necessity of extending molecular diagnosis coverage, which is vital for meeting national goals in eliminating TB. He reiterated that despite being a preventable and treatable illness, TB remains a critical global health issue due to the rise in drug-resistant strains.
Conclusion: A New Era for Tuberculosis Control
The introduction of two new GeneXpert devices represents a noteworthy advancement in the Dominican Republic’s public health landscape. By strengthening diagnostic capabilities, these additions facilitate the timely treatment of tuberculosis, thereby contributing positively to the nation’s health objectives. Ensuring early detection and effective monitoring will empower the country’s efforts in combating this persistent public health challenge.